Actively Recruiting
Feasibility and Safety Evaluation of GelPOINT4 Path Platform to Assist Endoscopic Removal of Colorectal Polyps
Led by Baylor College of Medicine · Updated on 2026-07-23
30
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the use of the GelPOINT4 Path transanal access platform during endoscopic submucosal dissection ESD for removing colorectal polyps. The study focuses on adult patients with eligible colorectal lesions and investigates the technical feasibility, procedural performance, and safety of using the GelPOINT4 Path system as part of standard clinical care. The study is prospective, single-center, and observational, enrolling about 30 adult participants. Participants will undergo ESD for colorectal polyps with the GelPOINT4 Path platform assisting the procedure. The platform is designed to improve access, maintain stable insufflation, and enhance visibility during the procedure. All procedures are performed by experienced endoscopists during routine care without experimental treatment changes. Data on procedure speed, technical success, resection completeness, device performance, operator workload, and adverse events will be collected. Throughout the study, participants will receive usual clinical care and be followed for approximately 4 weeks after the procedure to monitor for delayed adverse events. Researchers will collect clinical, procedural, pathological, and follow-up data using standardized forms. Key outcomes include procedure speed, en bloc resection rate, and complete R0 resection rate, with safety assessed during and after the procedure.
CONDITIONS
Brief Title
GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study
Research Team
T
Tara Keihanian, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here